2 recruiting, 1 withdrawn. 3 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 3 | Recruiting 2, Withdrawn 1 |
Follow IIM: new trials by email Literature Review of IIM trials Research Report on IIM
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of Anti-CD19/BCMA Universal CAR-T Cell Therapy RD06-05 in Patients With Autoimmune Diseases. RD06-05 CART Cell Injection - SLE, LN | Early Phase 1 | Recruiting | Nanjing Bioheng Biotech Co., Ltd. | 96 | 2025-07-24 | 2026-08-03 |
| Clinical Study on Targeted CD19/BCMA CAR-T Therapy for Autoimmune Diseases RD06-05 CART Cell Injection - SLE, Systemic Sclerosis | Early Phase 1 | Recruiting | Nanjing Bioheng Biotech Co., Ltd. | 18 | 2025-01-03 | 2026-02-02 |
| A Study of RD06-04 in Patients With Active Autoimmune Diseases RD06-04 cell infusion - SLE, Sclerosis | Early Phase 1 | Withdrawn | Nanjing Bioheng Biotech Co., Ltd. | 2024-08-31 | 2026-02-03 |
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (3) · Anti-Glomerular Basement Membrane Disease (1) · Glomerulonephritis, IGA (1) · Neuromyelitis Optica (1) · Scleroderma, Systemic (1) · Sclerosis (1)
Autoimmune Diseases (3) · Cardiovascular Diseases (3) · Immune System Diseases (3) · Skin Diseases (3) · Skin Diseases, Vascular (3) · Skin and Connective Tissue Diseases (3) · Systemic Vasculitis (3) · Vascular Diseases (3) · Vasculitis (3) · Autoimmune Diseases of the Nervous System (1) · Connective Tissue Diseases (1) · Cranial Nerve Diseases (1) · Demyelinating Autoimmune Diseases, CNS (1) · Demyelinating Diseases (1) · Eye Diseases (1)
Nanjing Bioheng Biotech Co., Ltd. (3)
China (3)